A prospective observational study of problematic oral cannabinoid use.

about

A prospective observational study of problematic oral cannabinoid use.

Item

http://www.wikidata.org/entity/Q47219944

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A prospective observational study of problematic oral cannabinoid use.

@en

A prospective observational study of problematic oral cannabinoid use.

@nl

type

Item

label

A prospective observational study of problematic oral cannabinoid use.

@en

A prospective observational study of problematic oral cannabinoid use.

@nl

prefLabel

A prospective observational study of problematic oral cannabinoid use.

@en

A prospective observational study of problematic oral cannabinoid use.

@nl

P1476

A prospective observational study of problematic oral cannabinoid use.

@en

P2093

Joel Singer

http://www.w3.org/2001/XMLSchema#string

Marc O Martel

http://www.w3.org/2001/XMLSchema#string

Mark A Ware

http://www.w3.org/2001/XMLSchema#string

Mary E Lynch

http://www.w3.org/2001/XMLSchema#string

Roman Jovey

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis

Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.

Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain.

Cannabis as a substitute for prescription drugs - a cross-sectional study

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Opioids for chronic noncancer pain: a new Canadian practice guideline

Psychological variables potentially implicated in opioid-related mortality as observed in clinical practice.

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.

Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy.

Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.

P2888

s00213-017-4811-6

P31

scholarly article

P356

10.1007/S00213-017-4811-6

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29250737

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoids